Traditional Chinese medicine composition for treating kidney deficiency type ovarian reserve function decline disease and application thereof

Abstract

The invention relates to a traditional Chinese medicine composition for treating kidney deficiency type ovarian reserve function decline diseases. The traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 10-14 parts of poria cocos, 8-12 parts of radix rehmanniae, 8-12 parts of radix rehmanniae preparata, 8-12 parts of glossy privet fruits, 8-12 parts of rhizoma curculiginis, 8-12 parts of herba epimedii, 8-12 parts of radix morindae officinalis, 8-12 parts of herba cistanche, 8-12 parts of cornu cervi degelatinatum and 28-32 parts of amethyst. The invention further provides application of the traditional Chinese medicine composition. The traditional Chinese medicine composition can effectively improve the endocrine hormone level of a DOR patient, improve the menstruation condition and relieve clinical symptoms, has a good clinical curative effect, is an effective proved recipe for treating the DOR, provides a thought and evidence-based medical evidence for treating the DOR through traditional Chinese medicine, and is worthy of further defining the action mechanism of the traditional Chinese medicine composition for improving the ovarian reserve function subsequently.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating kidney-deficiency type ovarian reserve function decline and its application. Background technique [0002] The etiology and pathogenesis of decreased ovarian reserve (DOR) are complex. With the increase of social pressure on women, the intensification of environmental pollution, and unhealthy living habits, the incidence of DOR is increasing year by year and showing a trend of younger age. At present, Western medicine mainly focuses on hormone replacement in treatment. Scholars at home and abroad believe that the application of HRT in patients with ovarian function decline can give HPOA a temporary rest and temporarily control the disease. Studies have shown that FSH can be significantly reduced after 3 months of treatment. However, although femotone can reduce the level of FSH, FSH may rebound after...

AI Technical Summary

Problems solved by technology

[0006] And at present about curative effect is remarkable, and side effect is little, and a kind of Chinese medicine composition for the treatment of kidney-deficiency type ovarian reserve function decline disease of rapid onset has not been reported yet.

Images